Stem signatures associating SOX2 antibody helps to define diagnosis and prognosis prediction with esophageal cancer

BACKGROUND: esophageal cancer is one of the deadliest diseases worldwide. Due to the ineffectual screening methods referring to early diagnosis, most people have lost their chance of radical resection when diagnosed with esophageal cancer. This aim of this study was designed to evaluate the latent v...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Zi-Yang, Wang, Qing-Shi, Li, Kai, Chen, Si-Si, Li, Xiang, Xiao, Guo-Dong, Tang, Shou-Ching, Ren, Hong, Wang, Zhe, Sun, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004505/
https://www.ncbi.nlm.nih.gov/pubmed/35382656
http://dx.doi.org/10.1080/07853890.2022.2056239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004505/
https://www.ncbi.nlm.nih.gov/pubmed/35382656
http://dx.doi.org/10.1080/07853890.2022.2056239

Ejemplares similares